The molecular mechanism underlying the phosphorylation of ATM/ATR/ERK, which mediates ZDHHC11, should be investigated for the hnRNP G‐T‐ZDHHC11 pathway to be used as a therapeutic target in CRC. Here, RBMX is linked to colorectal carcinoma.